Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut-associated lymphoid tissue (GALT) immune receptors and pattern recognition receptors (PRRs) are a heterogeneous group of proteins responsible for sensing the microbial environment of the gastrointestinal tract. These receptors, including Toll-like receptors (TLRs), NOD-like receptors (NLRs), and C-type lectin receptors (CLRs), are expressed by intestinal epithelial cells and underlying immune cells to detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) [1][2]. Their primary biological function is to maintain a delicate balance between tolerance toward commensal microbiota and active defense against pathogens [3]. In diseases like Crohn's disease and ulcerative colitis, mutations or dysregulation in these receptors (such as NOD2) lead to aberrant immune responses and chronic inflammation [4]. These receptors serve as critical checkpoints for the induction of both innate and adaptive immunity within the mucosal surface. Therapeutic strategies targeting these pathways include the use of biologics to block downstream inflammatory cytokines or small molecules to modulate specific receptor signaling [5]. Understanding the spatial distribution and signaling nuances of these receptors is essential for developing site-specific treatments for gastrointestinal disorders. Current research also explores the role of these receptors in the gut-brain axis and systemic metabolic health.
Modulation of innate and adaptive immune signaling pathways within the gut mucosa to restore homeostasis or suppress pathological inflammation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut-associated lymphoid tissue immune receptors and pattern recognition receptors (GALT PRRs).